Skip to main content
Pharmanutra logo

Pharmanutra — Investor Relations & Filings

Ticker · PHN ISIN · IT0005274094 LEI · 815600F8217BC7733697 XMIL Manufacturing
Open in API
Filings indexed 601 across all filing types
Latest filing 2021-03-08 Report Publication Anno…
Country IT Italy
Listing XMIL PHN

About Pharmanutra

http://www.pharmanutra.it

PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.

Recent filings

Filing Released Lang Actions
PR PHN - Modification corporate events 2021
Report Publication Announcement Classification · 1% confidence The document is an official regulatory announcement (Informazione Regolamentata) from an Italian company (Pharmanutra S.p.A.) dated March 8, 2021. The subject ('Oggetto') is 'PR PHN - Modification corporate events 2021'. The text explicitly states that the 2021 corporate events calendar is being modified, specifically mentioning a change to the date for the Board of Directors meeting to examine the 2020 Financial Statements. This is a formal announcement about a change in the schedule of future corporate events, not the release of the actual financial statements or a transcript. Since it is a formal announcement regarding corporate events/scheduling that doesn't fit perfectly into the other specific categories (like DIV, ER, or DIRS), it falls best under the general 'Regulatory Filings' category (RNS) as a miscellaneous regulatory update, or potentially a Report Publication Announcement (RPA) if it were announcing the publication of a report, but here it announces a change in the schedule for a future report examination. Given the nature of announcing a change to the corporate calendar, RNS is the most appropriate general regulatory fallback.
2021-03-08 English
CS PHN - Rettifica calendario eventi societari 2021
Report Publication Announcement Classification · 1% confidence The document is an Italian 'Informazione Regolamentata' (Regulated Information) dated March 8, 2021. The subject ('Oggetto') is 'CS PHN - Rettifica calendario eventi societari 2021' (CS PHN - Rectification of the 2021 corporate events calendar). The text explicitly states that the annual calendar of corporate events is being modified, specifically noting a change for the Board of Directors meeting to approve the 2020 Financial Statements on March 22, 2021. This is a formal announcement regarding a change in the schedule of future corporate events, rather than the release of the actual financial report or a general regulatory filing. Since it is an announcement about a corporate event schedule change, it does not fit perfectly into the defined categories like ER, IR, or 10-K. It is a specific corporate update. Given the options, this type of announcement, which concerns the timing of future corporate actions (like board meetings for financial approvals), is best categorized as a general Regulatory Filing (RNS) as it is a mandatory disclosure that doesn't fit the more specific financial report or management change codes. However, since it is a specific announcement about corporate events, and not a general regulatory filing fallback, I must re-evaluate. It is not a dividend (DIV), management change (MANG), or financing event (CAP). It is a procedural update. In the context of the provided definitions, RNS serves as the best general regulatory announcement category for non-standard disclosures. The document is short and announces a change, which aligns with the spirit of an announcement rather than a full report.
2021-03-08 Italian
CS PHN - eventi societari 2021 29_01_2021
Report Publication Announcement Classification · 1% confidence The document is a regulatory announcement (Informazione Regolamentata) from Pharmanutra S.p.A., dated January 29, 2021. The subject ('Oggetto') is 'CS PHN - eventi societari 2021' (Corporate Events Calendar 2021). The core content explicitly lists the dates for upcoming Board of Directors meetings to approve financial results (Annual Report, Quarterly Reports) and the date for the Shareholders' Meeting to approve the Annual Report. This document is not the financial report itself, but an announcement detailing *when* various reports and meetings will occur. This fits the definition of a Report Publication Announcement (RPA), which signals the release schedule of other mandatory reports.
2021-01-29 Italian
PR PHN - corporate events 2021 29_01_2021
Report Publication Announcement Classification · 1% confidence The document is a short press release dated January 29, 2021, titled "PHARMANUTRA S.P.A.: PUBLICATION OF THE 2021 CORPORATE EVENTS CALENDAR". It explicitly lists the dates for future Board of Directors meetings to examine financial results (including the 2020 Financial Statements, Q1 2021 Interim Statements, and H1 2021 Half-Yearly Report) and the Shareholders' Meeting. Since the document's primary function is to announce the schedule of future corporate reporting events rather than containing the reports themselves, it fits the definition of a Report Publication Announcement (RPA). The document length is short (5203 chars) and it announces the publication/examination of other reports, aligning with Rule 2.
2021-01-29 English
PR PHN - new advisory body 18_01_2021
Board/Management Information Classification · 1% confidence The document is a formal communication from an Italian company (PharmaNutra S.p.A.) marked as 'Informazione Regolamentata' (Regulated Information). The subject ('Oggetto') is 'PR PHN - new advisory body 18_01_2021'. The content announces the appointment of a Supervisory Body pursuant to Legislative Decree 231/2001. This type of announcement concerns the internal governance structure and management oversight of the company, specifically related to compliance and board structure. This aligns best with the 'Board/Management Information' (MANG) category, as it details a change in a key oversight body, which is closely related to management and governance structure announcements. It is not a full financial report (10-K, IR), an earnings release (ER), or a general regulatory filing (RNS), as it addresses a specific internal governance change.
2021-01-18 English
CS PHN - nomina OdV 18_01_2021
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement (Informazione Regolamentata) from an Italian company (Pharmanutra S.p.A.) dated January 18, 2021. The subject ('Oggetto') is 'CS PHN - nomina OdV 18_01_2021', which translates to the appointment of the Supervisory Body (Organismo di Vigilanza - OdV) as required by Italian Legislative Decree 231/2001. This concerns changes in internal governance structure and compliance personnel, specifically the appointment of the Board of Auditors/Supervisory Body. This fits best under Board/Management Information (MANG) as it relates to key oversight personnel appointments, or potentially Governance Information (CGR). Since it is a specific announcement about the composition of a key compliance/oversight body, MANG is a strong fit, as it covers management/board changes. Given the short length and the nature of announcing a specific internal appointment, it is not a full report (like 10-K or AR). MANG covers changes in senior management/board, and the OdV is a critical governance/oversight body. Comparing MANG (Board/Management Information) and CGR (Governance Information): MANG is typically for appointments/resignations of directors/executives. CGR is for rules/structure. The appointment of the OdV is a specific personnel change related to compliance oversight, making MANG the most appropriate fit among the provided options for an announcement of a new oversight committee composition.
2021-01-18 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.